Openevidence was founded in 2022 by daniel nadler, a harvard ph.d And former founder of kensho, a financial analytics firm acquired by s&p global in 2018 Open evidence is an experimental technology that cannot fully substitute your clinical judgement and assessment of current guidelines/literature when making clinical decisions. Physicians treating patients with complex symptoms face a familiar challenge Sifting through thousands of medical studies to find relevant evidence whilst patients wait. You can get the most recent evidence, data, and research
Use the information to form clinical questions Examples of queries i wrote The american college of cardiology (acc) and openevidence are entering a strategic partnership to accelerate the translation of cardiovascular clinical guidance and research into clinical. In this update, openevidence maintains its emphasis on grounding information in verifiable, trustworthy sources and builds on that foundation to support a wide range of physician needs.
WATCH
